Physician profile
Daniel M Radack
NPI 1942261359
$823.04
in general payments reported to CMS, 2019-2025
13 companies · $358 in 2025
The $358 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $27.83 · 2021: $62.73 · 2022: $164 · 2024: $61.47 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Delcath Systems | $184.05 | 2025 | Hepzato Kit |
| Medtronic, INC. | $124.80 | 2022 | |
| Medtronic Vascular, INC. | $82.95 | 2019 | |
| Cook Medical LLC | $80.09 | 2025 | Tornado, Cook |
| Penumbra, INC. | $68.59 | 2025 | Ruby Coil |
| Bard Peripheral Vascular, INC. | $62.61 | 2019-2021 | |
| Becton, Dickinson and Company | $49.34 | 2024-2025 | Covera, Dorado |
| Cardinal Health 200 LLC | $43.12 | 2020-2021 | |
| Silk Road Medical, INC. | $39.29 | 2022 | |
| Cormedix INC. | $37.32 | 2024 | Defencath |
| Covidien LP | $24.99 | 2019 | |
| Medtronic USA, INC. | $13.15 | 2019 | |
| Philips North America LLC | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Radack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.